Laouan Brem Falmata, Rasras Hammam, El Ouafi Noha, Bazid Zakaria
Cardiology, Mohammed VI University Hospital, Mohammed I University, Oujda, MAR.
Cureus. 2021 Mar 12;13(3):e13848. doi: 10.7759/cureus.13848.
Hypercoagulability state is common in patients with coronavirus disease 2019 (COVID-19), especially those requiring intensive care. Indeed, anticoagulation therapy is recommended for all hospitalized COVID-19-patients. Despite well-conducted thromboprophylaxis, so many patients have developed these life-threatening complications. However, these thrombotic events are not known to occur in asymptomatic COVID-19 patients or in those recovered from active severe acute respiratory syndrome coronavirus 2 infection. This case series of a bilateral pulmonary embolism that occurred in patients recovered from asymptomatic COVID-19 highlights the questions about extending thromboprophylaxis in ambulatory patients with COVID-19.
高凝状态在2019冠状病毒病（COVID-19）患者中很常见，尤其是那些需要重症监护的患者。事实上，建议对所有住院的COVID-19患者进行抗凝治疗。尽管进行了良好的血栓预防，但仍有许多患者出现了这些危及生命的并发症。然而，无症状COVID-19患者或从严重急性呼吸综合征冠状病毒2感染中康复的患者并未出现这些血栓形成事件。这一系列关于从无症状COVID-19康复的患者发生双侧肺栓塞的病例，凸显了关于扩大对COVID-19门诊患者进行血栓预防的问题。
